Cholesterol Goals Established for Patients with Diabetes and Metabolic SyndromeBySteven M. Haffner, MDJanuary 1st 2002
Dyslipidemia of Insulin Resistance Syndrome Explained; Need for Treatment to Reduce Risk EmphasizedByHenry N. Ginsberg, MDJanuary 1st 2002
Review of Clinical trial Data Reaffirms Safety of Statin TherapyByAntonio M. Gotto, Jr, MD, DPhilJanuary 1st 2002
Protective Effects of HDL-C and Need to Raise Low Levels ExploredByDaniel J. Rader, MDJanuary 1st 2002
Risk Factors Common to Insulin Resistance and Atherosclerosis Explain Why Diabetes is a Cardiovascular DiseaseByHenry N. Ginsberg, MDJanuary 1st 2002
Heart Protection Study Finds Simvastatin Reduces Vascular Risk in a Wide Range of High-Risk PatientsByRory Collins, MB, BSJanuary 1st 2002
Lipid-Lowering Therapy Stabilizes Plaque Reduces Events by Limiting InflammationByPeter Libby, MDJanuary 1st 2002
